Fundz

I2 O Therapeutics, Inc. reported raising $3.2 Million in an initial SEC Form D filing, from an offering of $3.2 Million

PRIVATEMar 23, 2020

Amount Raised

$3.2 Million

$3.2 Million sold, per SEC Form D (first sale Mar 23, 2020)

Round Type

Seed

BostonBiotechnologyHealth CareTherapeutics

Quick answer

i2O Therapeutics, Inc. raised $3.2 Million in a Seed round, dated March 23, 2020. i2O Therapeutics, Inc. is based in Boston, Massachusetts, United States.

How much did i2O Therapeutics, Inc. raise?
i2O Therapeutics, Inc. raised $3.2 Million in a Seed round on March 23, 2020.
What does i2O Therapeutics, Inc. do?
i2o Therapeutics is a private biotechnology company that was founded in 2019 to exploit the versatile properties of ionic liquids for producing oral biologics and peptides. i2o has also acquired wholly owned proprietary..
Where is i2O Therapeutics, Inc. based and how big is it?
i2O Therapeutics, Inc. is based in Boston, Massachusetts, United States.

Source: Fundz verified event record.

Who else raised in Therapeutics and Biotechnology around the same time

Companies in the same sectors as i2O Therapeutics, Inc. that raised within 45 days of this round, from Fundz verified event records.

  • Ocugen raised $395 (Pre-Seed) on May 7, 2020.
  • Ocugen raised $14M on May 7, 2020.
  • Oragenics raised $4.6M (Seed) on May 6, 2020.
  • Os Therapies raised an undisclosed amount on May 1, 2020.
  • Alpha Cognition raised $1.9M (Seed) on May 1, 2020.
  • Fate Therapeutics raised $50M on April 21, 2020.

Who to call at i2O Therapeutics, Inc., and when

A new round usually means i2O Therapeutics, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day i2O Therapeutics, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at i2O Therapeutics, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at i2O Therapeutics, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

i2O Therapeutics, Inc.

Location

13250 VIA ARRIBA DRIVE

Boston, Massachusetts, United States

About

i2o Therapeutics is a private biotechnology company that was founded in 2019 to exploit the versatile properties of ionic liquids for producing oral biologics and peptides. i2o has also acquired wholly owned proprietary peptides with an intent to advance novel therapies for serious cardiometabolic diseases. As a complement to the oral ionic liquids approach, i2o also owns the rights to a sustained delivery system (small osmotic implants - Medici™) that enables just twice-yearly maintenance dosing of chronic medications. With this scope of platform technologies and proprietary peptides, i2o’s initial aim is to form strategic partnerships and to advance meaningful innovations that achieve a new standard of care for patients suffering from T2DM, Obesity, and related diseases. Over time, i2o’s platforms will also be leveraged for other opportunities and collaborations.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment i2O Therapeutics, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for i2O Therapeutics, Inc.'s next move

See what Strategic adds

i2O Therapeutics, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.